this report says it............
http://www.schizophreniaforum.org/new/detail.asp?id=2276
EVP-6124 is being tested in Phase 3 in schizophrenia patients as well. Two of these ongoing trials are fully enrolled (see clinicaltrials.gov, and trial); the third is still recruiting (see clinicaltrials.gov). The FDA has stipulated that the two enrolled trials, which are efficacy trials, can continue, while they put the newest trial, a safety extension, on hold. FORUM Pharmaceuticals declined to comment on the reason for this hold.
Edit:Nevermind, that article is old. It has failed.
1 Like
Yes encenecline failed
1 Like
Yes - it has failed in phase 3 testing. But - lots of other new medications in the pipeline and some of them will eventually make it to market.
1 Like